As of Apr 20
| +0.11 / +2.21%|
The 5 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +57.48% increase from the last price of 5.08.
The current consensus among 6 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.